As long as specific tissue probability priors are provided for a structural
sequence of interest (e.g., T2* weighted GM, WM, CSF priors), does it really
matter whether VBM is conducted on T1 data or not? Any issues with
unmodulated vs. modulated data when working with segmented data other than
T1? Has anyone had luck using VBM with FSE-type sequences? Would VBM2 or
VBM5 be more appropriate for attempting VBM with sequences other than T1?
Appreciate any input, tips, or suggestions in this matter.
Regards to all,
Jeff Browndyke
--------------------------
Duke Univ. Medical Center
Dept. of Psychiatry
Bryan ADRC
|